AP9400637A0 - Therapeutic c compounds - Google Patents
Therapeutic c compoundsInfo
- Publication number
- AP9400637A0 AP9400637A0 AP9400637A AP9400637A AP9400637A0 AP 9400637 A0 AP9400637 A0 AP 9400637A0 AP 9400637 A AP9400637 A AP 9400637A AP 9400637 A AP9400637 A AP 9400637A AP 9400637 A0 AP9400637 A0 AP 9400637A0
- Authority
- AP
- ARIPO
- Prior art keywords
- therapeutic
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
- C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
- C07C49/233—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
- C07C49/235—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939308652A GB9308652D0 (en) | 1993-04-27 | 1993-04-27 | Anti-inflammatory compounds |
| GB939318432A GB9318432D0 (en) | 1993-09-06 | 1993-09-06 | Anti-inflammatory compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9400637A0 true AP9400637A0 (en) | 1994-04-30 |
| AP454A AP454A (en) | 1996-01-19 |
Family
ID=26302815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1994/000637A AP454A (en) | 1993-04-27 | 1994-04-26 | Therapeutic compounds with hydroxamic acid derivatives. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0696272A1 (en) |
| JP (1) | JPH08509718A (en) |
| AP (1) | AP454A (en) |
| AU (1) | AU6575094A (en) |
| CA (1) | CA2161544A1 (en) |
| HU (1) | HUT71556A (en) |
| IL (1) | IL109430A0 (en) |
| TW (1) | TW269679B (en) |
| WO (1) | WO1994025431A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3322885B2 (en) | 1995-02-02 | 2002-09-09 | 日研化学株式会社 | N-hydroxyurea derivative |
| JPH11507670A (en) * | 1995-06-12 | 1999-07-06 | ジー.ディー.サール アンド カンパニー | Treatment of inflammation and inflammation-related diseases with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| CN1315858A (en) * | 1998-07-17 | 2001-10-03 | 富士药品工业株式会社 | Novel remedies for allergic diseases |
| US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| AR038957A1 (en) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | COMBINATION THERAPY FOR CANCER TREATMENT |
| AU2003205461B2 (en) | 2002-02-15 | 2006-08-31 | Endorecherche, Inc. | Biphenyl Derivatives and their Use as Antiandrogenic Agents |
| CN112358416B (en) * | 2020-11-03 | 2021-10-15 | 北京科技大学 | A kind of preparation method of trans-3-chloro-2-propenyl hydroxylamine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT82200B (en) * | 1985-03-16 | 1990-02-08 | Wellcome Found | METHOD FOR PREPARING NEW DERIVATIVES OF HYDROXAMIC ACID AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| EP0351214A1 (en) * | 1988-07-14 | 1990-01-17 | The Wellcome Foundation Limited | Anti-inflammatory aryl derivatives |
-
1994
- 1994-04-26 CA CA002161544A patent/CA2161544A1/en not_active Abandoned
- 1994-04-26 AP APAP/P/1994/000637A patent/AP454A/en active
- 1994-04-26 HU HU9501810A patent/HUT71556A/en unknown
- 1994-04-26 TW TW083103703A patent/TW269679B/zh active
- 1994-04-26 IL IL10943094A patent/IL109430A0/en unknown
- 1994-04-26 EP EP94913700A patent/EP0696272A1/en not_active Withdrawn
- 1994-04-26 AU AU65750/94A patent/AU6575094A/en not_active Abandoned
- 1994-04-26 JP JP6524019A patent/JPH08509718A/en active Pending
- 1994-04-26 WO PCT/GB1994/000886 patent/WO1994025431A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0696272A1 (en) | 1996-02-14 |
| JPH08509718A (en) | 1996-10-15 |
| WO1994025431A1 (en) | 1994-11-10 |
| CA2161544A1 (en) | 1994-11-10 |
| HU9501810D0 (en) | 1995-08-28 |
| IL109430A0 (en) | 1994-07-31 |
| HUT71556A (en) | 1995-12-28 |
| AP454A (en) | 1996-01-19 |
| AU6575094A (en) | 1994-11-21 |
| TW269679B (en) | 1996-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0714302A4 (en) | Therapeutic compounds | |
| GB9421709D0 (en) | Therapeutic compounds | |
| AP9600895A0 (en) | Therapeutic compounds | |
| GB9300051D0 (en) | Therapeutic agents | |
| AU6092794A (en) | Oxime-substituted therapeutic compounds | |
| EP0739200A4 (en) | Therapeutic substituted guanidines | |
| GB9310199D0 (en) | Therapeutic compounds | |
| GB9312204D0 (en) | Therapeutic composition | |
| GB9307013D0 (en) | Therapeutic combinations | |
| AP9400637A0 (en) | Therapeutic c compounds | |
| ZA946217B (en) | Therapeutic combination | |
| ZA942911B (en) | Therapeutic compounds | |
| GB9117819D0 (en) | Therapeutic compounds | |
| GB9316943D0 (en) | Therapeutic compounds | |
| GB9316931D0 (en) | Therapeutic compounds | |
| GB9226526D0 (en) | Therapeutic compounds | |
| GB9222934D0 (en) | Therapeutic compounds | |
| GB9308962D0 (en) | Therapeutic agetns | |
| GB9306646D0 (en) | Therapeutic agetns | |
| GB9222633D0 (en) | Therapeutic agetns | |
| GB9416632D0 (en) | Therapeutic compounds | |
| GB9416629D0 (en) | Therapeutic compounds | |
| SI0769017T1 (en) | Therapeutic compounds | |
| GB9124541D0 (en) | Therapeutic compounds | |
| GB9102376D0 (en) | Therapeutic compounds |